<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Structurally optimized potent dual-targeting NBTI antibacterials with an enhanced bifurcated halogen-bonding propensity</dc:title><dc:creator>Kokot,	Maja	(Avtor)
	</dc:creator><dc:creator>Weiss,	Matjaž	(Avtor)
	</dc:creator><dc:creator>Zdovc,	Irena	(Avtor)
	</dc:creator><dc:creator>Hrast Rambaher,	Martina	(Avtor)
	</dc:creator><dc:creator>Anderluh,	Marko	(Avtor)
	</dc:creator><dc:creator>Minovski,	Nikola	(Avtor)
	</dc:creator><dc:subject>NBTIs</dc:subject><dc:subject>DNA gyrase</dc:subject><dc:subject>topoisomerase IV</dc:subject><dc:subject>bifurcated halogen bonds</dc:subject><dc:subject>dual targeting</dc:subject><dc:description>We designed and synthesized an optimized library of novel bacterial topoisomerase inhibitors with p-halogenated phenyl right-hand side fragments and significantly enhanced and balanced dual-targeted DNA gyrase and topoisomerase IV activities of Staphylococcus aureus and Escherichia coli. By increasing the electron-withdrawing properties of the p-halogenated phenyl right-hand side fragment and maintaining a similar lipophilicity and size, an increased potency was achieved, indicating that the antibacterial activities of this series of novel bacterial topoisomerase inhibitors against all target enzymes are determined by halogen-bonding rather than van der Waals interactions. They show nanomolar enzyme inhibitory and whole-cell antibacterial activities against S. aureus and methicillin-resistant S. aureus (MRSA) strains. However, due to the relatively high substrate specificity for the bacterial efflux pumps, they tend to be less potent against E. coli and other Gram-negative pathogens.</dc:description><dc:date>2021</dc:date><dc:date>2022-09-29 12:56:15</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>141453</dc:identifier><dc:identifier>UDK: 615.4:54:579</dc:identifier><dc:identifier>ISSN pri članku: 1948-5875</dc:identifier><dc:identifier>DOI: 10.1021/acsmedchemlett.1c00345</dc:identifier><dc:identifier>COBISS_ID: 73185027</dc:identifier><dc:language>sl</dc:language></metadata>
